Thomas Mika
Board Member
ENvue Medical, Inc. (FEED)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thomas Mika
Thomas Mika is recorded as Board Member at ENvue Medical, Inc. (FEED). ENvue Medical, Inc. reported in an 8-K filed December 5, 2025 that Thomas Mika retired as director, effective December 4, 2025. ENvue Medical, Inc. reported in an 8-K filed December 20, 2024 that Thomas Mika was appointed Director, effective December 19, 2024. ENvue Medical, Inc. reported in an 8-K filed December 15, 2022 that Thomas Mika was appointed director, effective December 15, 2022.
“Immediately prior to the Annual Meeting, each of Christopher Fashek, Thomas Mika, Martin Goldstein, M.D., and Brian Murphy ceased to be directors of the Board and all committees thereto.”
“A proposal to elect eight nominees to serve on the Company’s board of directors , for a term of one year or until their respective successors are elected and qualified, for which the following are nominees: Aurora Cassirer, Christopher Fashek, Michael Ferguson, Martin Goldstein, M.D., Harold Jacob, M.D., Thomas Mika, Brian Murphy, and Maria Schroeder.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-12-19–present
-
2024-12-19–2025-12-04
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at ENvue Medical, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Murphy CEO, Board Member
- Doron Besser CEO, Board Member
- Doron Besser, M.D. CEO, Board Member
- David Johnson Chairman, Board Member
- Zeev Rotstein Chairman, Board Member
- Nicole Fernandez-McGovern CFO
- Stephen Brown CFO
- Rita Silberberg Chief Accounting Officer
- Alison Geiger Burgett Board Member
- Aurora Cassirer Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.